Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
about
Expression of EZH2 in endometrial carcinoma and its effects on proliferation and invasion of endometrial carcinoma cells.Modeling Endometrial Cancer: Past, Present, and FutureUpregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin
P2860
Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Oncogenic histone methyltransf ...... otential in endometrial cancer
@en
type
label
Oncogenic histone methyltransf ...... otential in endometrial cancer
@en
prefLabel
Oncogenic histone methyltransf ...... otential in endometrial cancer
@en
P2093
P2860
P356
P1433
P1476
Oncogenic histone methyltransf ...... otential in endometrial cancer
@en
P2093
Aki Miyasaka
Daichi Maeda
Hiroyuki Kuramoto
Katsutoshi Oda
Kei Kawana
Kenbun Sone
Makoto Takeuchi
Masako Ikemura
Masashi Fukayama
Mayuyo Mori-Uchino
P2860
P304
40402-40411
P356
10.18632/ONCOTARGET.16316
P407
P577
2017-06-01T00:00:00Z